Annual CAPEX:
$2.60M-$2.00M(-43.46%)Summary
- As of today, INBX annual capital expenditures is $2.60 million, with the most recent change of -$2.00 million (-43.46%) on December 31, 2024.
- During the last 3 years, INBX annual CAPEX has risen by +$1.73 million (+200.58%).
- INBX annual CAPEX is now -43.46% below its all-time high of $4.59 million, reached on December 31, 2023.
Performance
INBX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$10.00K+$10.00K(+100.00%)Summary
- As of today, INBX quarterly capital expenditures is $10.00 thousand, with the most recent change of +$10.00 thousand (+100.00%) on September 30, 2025.
- Over the past year, INBX quarterly CAPEX has dropped by -$237.00 thousand (-95.95%).
- INBX quarterly CAPEX is now -99.18% below its all-time high of $1.22 million, reached on June 30, 2024.
Performance
INBX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$47.00K-$237.00K(-83.45%)Summary
- As of today, INBX TTM capital expenditures is $47.00 thousand, with the most recent change of -$237.00 thousand (-83.45%) on September 30, 2025.
- Over the past year, INBX TTM CAPEX has dropped by -$2.53 million (-98.18%).
- INBX TTM CAPEX is now -98.19% below its all-time high of $2.60 million, reached on December 31, 2024.
Performance
INBX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
INBX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -43.5% | -96.0% | -98.2% |
| 3Y3 Years | +200.6% | -50.0% | -93.5% |
| 5Y5 Years | +43.5% | -96.7% | -95.7% |
INBX CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -43.5% | +278.6% | -99.2% | >+9999.0% | -98.2% | at low |
| 5Y | 5-Year | -43.5% | +278.6% | -99.2% | >+9999.0% | -98.2% | at low |
| All-Time | All-Time | -43.5% | +278.6% | -99.2% | >+9999.0% | -98.2% | at low |
INBX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $10.00K(>+9900.0%) | $47.00K(-83.5%) |
| Jun 2025 | - | $0.00(-100.0%) | $284.00K(-81.1%) |
| Mar 2025 | - | $21.00K(+31.3%) | $1.50M(-42.3%) |
| Dec 2024 | $2.60M(-43.5%) | $16.00K(-93.5%) | $2.60M(+0.6%) |
| Sep 2024 | - | $247.00K(-79.7%) | $2.58M(+10.6%) |
| Jun 2024 | - | $1.22M(+8.6%) | $2.33M(+62.5%) |
| Mar 2024 | - | $1.12M(+253.0%) | $1.44M(+129.0%) |
| Dec 2023 | $4.59M(+569.5%) | - | - |
| Jun 2023 | - | $317.00K(+1278.3%) | $627.00K(-0.8%) |
| Mar 2023 | - | $23.00K(-91.4%) | $632.00K(-12.9%) |
| Dec 2022 | $686.00K(-20.6%) | $267.00K(+1235.0%) | $726.00K(0.0%) |
| Sep 2022 | - | $20.00K(-93.8%) | $726.00K(-17.0%) |
| Jun 2022 | - | $322.00K(+175.2%) | $875.00K(-9.5%) |
| Mar 2022 | - | $117.00K(-56.2%) | $967.00K(+11.9%) |
| Dec 2021 | $864.00K | $267.00K(+58.0%) | $864.00K(-28.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $169.00K(-59.2%) | $1.21M(-9.7%) |
| Jun 2021 | - | $414.00K(+2857.1%) | $1.34M(+4.0%) |
| Mar 2021 | - | $14.00K(-97.7%) | $1.29M(-5.6%) |
| Dec 2020 | $1.36M(-24.6%) | $612.00K(+104.7%) | $1.36M(+25.5%) |
| Sep 2020 | - | $299.00K(-17.4%) | $1.09M(-27.5%) |
| Jun 2020 | - | $362.00K(+297.8%) | $1.50M(-17.8%) |
| Mar 2020 | - | $91.00K(-72.8%) | $1.82M(+0.8%) |
| Dec 2019 | $1.81M(+26.7%) | $335.00K(-52.9%) | $1.81M(+22.7%) |
| Sep 2019 | - | $711.00K(+3.5%) | $1.48M(+93.1%) |
| Jun 2019 | - | $687.00K(+792.2%) | $764.00K(+29.9%) |
| Mar 2019 | - | $77.00K(-84.9%) | $588.00K(+0.3%) |
| Dec 2018 | $1.43M(+6.6%) | - | - |
| Jun 2018 | - | $511.00K(+581.3%) | $586.00K(+681.3%) |
| Mar 2018 | - | $75.00K | $75.00K |
| Dec 2017 | $1.34M | - | - |
FAQ
- What is Inhibrx Biosciences, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. annual CAPEX year-on-year change?
- What is Inhibrx Biosciences, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. quarterly CAPEX year-on-year change?
- What is Inhibrx Biosciences, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. TTM CAPEX year-on-year change?
What is Inhibrx Biosciences, Inc. annual capital expenditures?
The current annual CAPEX of INBX is $2.60M
What is the all-time high annual CAPEX for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high annual capital expenditures is $4.59M
What is Inhibrx Biosciences, Inc. annual CAPEX year-on-year change?
Over the past year, INBX annual capital expenditures has changed by -$2.00M (-43.46%)
What is Inhibrx Biosciences, Inc. quarterly capital expenditures?
The current quarterly CAPEX of INBX is $10.00K
What is the all-time high quarterly CAPEX for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high quarterly capital expenditures is $1.22M
What is Inhibrx Biosciences, Inc. quarterly CAPEX year-on-year change?
Over the past year, INBX quarterly capital expenditures has changed by -$237.00K (-95.95%)
What is Inhibrx Biosciences, Inc. TTM capital expenditures?
The current TTM CAPEX of INBX is $47.00K
What is the all-time high TTM CAPEX for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high TTM capital expenditures is $2.60M
What is Inhibrx Biosciences, Inc. TTM CAPEX year-on-year change?
Over the past year, INBX TTM capital expenditures has changed by -$2.53M (-98.18%)